Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029, USA.
Heart. 2013 Jun;99(12):849-53. doi: 10.1136/heartjnl-2013-303672. Epub 2013 Mar 20.
The objective of this study was to investigate the impact of bilateral internal mammary artery (BIMA) on early outcomes after coronary artery bypass grafting.
Retrospective database analysis.
US hospitals.
1 526 360 patients (mean age 65 years, 73% male) from the Nationwide Inpatient Sample from 2002-2008 who underwent isolated coronary artery bypass grafting with at least one internal mammary artery.
Single versus BIMA bypass grafting.
Inhospital mortality, deep sternal wound infection (DSWI).
The rate of BIMA use was 3.9%. Use of BIMA was independently associated with slightly lower inhospital mortality (unadjusted rate 1.1% vs 1.7%, adjusted OR 0.86, 95% CI 0.79 to 0.93). The DSWI rate was 1.4%. The independent predictors of DSWI were female gender (OR 1.06), congestive heart failure (OR 6.22), chronic pulmonary disease (OR 1.57), obesity (OR 1.17), diabetes mellitus (OR 1.04; OR 1.51 with chronic complication) and chronic renal failure (OR 2.13; OR 2.63 with dialysis). The use of BIMA was not an independent predictor of DSWI (OR 1.03, 95% CI 0.96 to 1.10). BIMA was associated with higher incidence of DSWI in patients with chronic complications of diabetes mellitus (OR 1.90, 95% CI 1.51 to 2.41).
BIMA grafting is associated with increased risk of DSWI only in patients with severe, chronic diabetes. The incremental morbidity and mortality of DSWI does not justify denial of BIMA in the majority of patients.
本研究旨在探讨双侧内乳动脉(BIMA)对冠状动脉旁路移植术后早期结果的影响。
回顾性数据库分析。
美国医院。
2002 年至 2008 年间,从全国住院患者样本中选取了 1526360 例(平均年龄 65 岁,73%为男性)接受了至少一支内乳动脉的单纯冠状动脉旁路移植术的患者。
单支与 BIMA 旁路移植术。
住院死亡率、深部胸骨伤口感染(DSWI)。
BIMA 使用率为 3.9%。BIMA 的使用与住院死亡率略有降低相关(未调整的死亡率为 1.1%比 1.7%,调整后的 OR 0.86,95%CI 0.79 至 0.93)。DSWI 发生率为 1.4%。DSWI 的独立预测因素为女性(OR 1.06)、充血性心力衰竭(OR 6.22)、慢性肺部疾病(OR 1.57)、肥胖(OR 1.17)、糖尿病(OR 1.04;伴有慢性并发症时为 1.51)和慢性肾衰竭(OR 2.13;伴有透析时为 2.63)。BIMA 的使用不是 DSWI 的独立预测因素(OR 1.03,95%CI 0.96 至 1.10)。BIMA 与伴有糖尿病慢性并发症患者的 DSWI 发生率升高相关(OR 1.90,95%CI 1.51 至 2.41)。
BIMA 移植仅在患有严重慢性糖尿病的患者中与 DSWI 风险增加相关。DSWI 的增量发病率和死亡率并不能证明在大多数患者中拒绝 BIMA 是合理的。